Question 1

What is ETRANACOGENE DEZAPARVOVEC used for?

Accepted Answer

ETRANACOGENE DEZAPARVOVEC (brand name HEMGENIX) is a Other indicated for or Have current or historical life-threatening hemorrhage, or Have repeated, or Have current or historical life-threatening hemorrhage.

Question 2

How does ETRANACOGENE DEZAPARVOVEC work?

Accepted Answer

ETRANACOGENE DEZAPARVOVEC works through the following mechanism: 12.1 Mechanism of Action HEMGENIX is an adeno-associated virus serotype 5 (AAV5) based gene therapy designed to deliver a copy of a gene encoding the Padua variant of human coagulation Factor IX (hFIX-Padua). Single intravenous infusion of HEMGENIX results in cell transduction and increase in circulating Factor IX activity in patients with Hemophilia B..

Question 3

What are the most common side effects of ETRANACOGENE DEZAPARVOVEC?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for ETRANACOGENE DEZAPARVOVEC. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is ETRANACOGENE DEZAPARVOVEC the same as HEMGENIX?

Accepted Answer

HEMGENIX is a brand name for ETRANACOGENE DEZAPARVOVEC. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

ETRANACOGENE DEZAPARVOVEC

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations